2025 Eberhard F. Mammen Award Announcements–Part II: Young Investigator Awards

Permissions and Reprints (opens in new window) Welcome to the latest of our Eberhard F. Mammen award announcements. As noted many times previously, Thieme, the publisher of Seminars in Thrombosis and Hemostasis (STH), has created the “Eberhard F. Mammen Excellence in Thrombosis and Hemostasis Awards” in honor of Eberhard F. Mammen ([ Fig. 1 ]), and in recognition of his contribution to this field, and to the journal that he both founded and steered for over three decades (see [ Table 1 ] for relevant Editorials related to past awards). These awards began in 2009, under two categories; the current award details and conditions are as follows: Fig. 1 Eberhard F. Mammen (1930–2008). Table 1 Listing of relevant editorials published in STH as related to the initiation of the Eberhard F Mammen awards, as well as previous award announcements 1. Favaloro EJ. Welcome to a Special Issue of Seminars in Thrombosis and Hemostasis—The Closing Issue for 2008. Semin Thromb Hemost 2008;34(8):693–696 2. Favaloro EJ. A Tribute to Eberhard F. Mammen, M.D. (1930–2008). Semin Thromb Hemost 2008;34(8):703–708 3. Favaloro EJ. Welcome to the first issue of Seminars in Thrombosis and Hemostasis for 2009. Semin Thromb Hemost 2009;35(1):1–2 4. Favaloro EJ. Winners of the Inaugural Eberhard F. Mammen Award for Most Popular Article. Semin Thromb Hemost 2009;35(7):587–590 5. Favaloro EJ. 2009 Eberhard F. Mammen Young Investigator Award Winners. Semin Thromb Hemost 2010;36(5):469–470 6. Favaloro EJ. Winners of the 2010 Eberhard F. Mammen Award for Most Popular Article during 2008–2009. Semin Thromb Hemost. 2010;36(7):685–692 7. Favaloro EJ. 2011 Eberhard F. Mammen award announcements. Semin Thromb Hemost 2011;37(5):431–439 8. Favaloro EJ. 2012 Eberhard F. Mammen Award Announcements. Semin Thromb Hemost 2012;38(5):425–432 9. Favaloro EJ. 2013 Eberhard F. Mammen Award Announcements. Semin Thromb Hemost 2013;39(6):567–574 10. Favaloro EJ. 2014 Eberhard F. Mammen Award Announcements: Part I-Most Popular Articles. Semin Thromb Hemost 2014;40(4):407–412 11. Favaloro EJ. 2014 Eberhard F. Mammen Award Announcements: Part II - Young Investigator Awards. Semin Thromb Hemost 2014;40(7):718–723 12. Favaloro EJ. 2015 Eberhard F. Mammen Award Announcements: Part I-Most Popular Articles. Semin Thromb Hemost 2015;41(7):673–679 13. Favaloro EJ. 2015 Eberhard F. Mammen Award Announcements: Part II-Young Investigator Awards. Semin Thromb Hemost 2015;41(8):809–815 14. Favaloro EJ. 2016 Eberhard F. Mammen Award Announcements: Part I - Most Popular Articles. Semin Thromb Hemost 2016;42(4):325–330 15. Favaloro EJ. 2016 Eberhard F. Mammen Award Announcements: Part II-Young Investigator Awards. Semin Thromb Hemost 2017;43(3):235–241 16. Favaloro EJ. 2017 Eberhard F. Mammen Award Announcements: Part I-Most Popular Articles. Semin Thromb Hemost 2017;43(4):357–363 17. Favaloro EJ. 2017 Eberhard F. Mammen Award Announcements: Part II- Young Investigator Awards. Semin Thromb Hemost 2018;44(2):81–88 18. Favaloro EJ. 2018 Eberhard F. Mammen Award Announcements: Part I-Most Popular Articles. Semin Thromb Hemost 2018;44(3):185–192 19. Favaloro EJ. 2018 Eberhard F. Mammen Award Announcements: Part II-Young Investigator Awards. Semin Thromb Hemost 2019;45(2):123–129 20. Favaloro EJ. 2019 Eberhard F. Mammen Award Announcements: Part I-Most Popular Articles. Semin Thromb Hemost 2019;45(3):215–224 21. Favaloro EJ. 2019 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards. Semin Thromb Hemost 2020;46(2):105–113 22. Favaloro EJ. 2020 Eberhard F. Mammen Award Announcements: Part I-Most Popular Articles. Semin Thromb Hemost 2020;46(4):383–392 23. Favaloro EJ. 2020 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards. Semin Thromb Hemost 2021;47(3):229–237 24. Favaloro EJ. 2021 Eberhard F. Mammen Award Announcements: Part I-Most Popular Articles. Semin Thromb Hemost 2021;47(5):467–476 25. Favaloro EJ. 2021 Eberhard F. Mammen Award Announcements: Part II-Young Investigator Awards. Semin Thromb Hemost 2022;48(3):265–273 26. Favaloro EJ. 2022 Eberhard F. Mammen Award Announcements: Part I-Most Popular Articles. Semin Thromb Hemost 2022;48(5):502–513 27. Favaloro EJ. 2022 Eberhard F. Mammen Award Announcements: Part II-Young Investigator Awards. Semin Thromb Hemost 2023;49(8):775–782 28. 2023 Eberhard F. Mammen Award Announcements: Part I-Most Popular Articles. Semin Thromb Hemost. 2023;49(5):417–426 29. Favaloro EJ. 2024 Eberhard F. Mammen Award Announcements: Part I-Most Popular Articles. Semin Thromb Hemost 2024;50(7):919–932 30. Favaloro EJ. 2023 Eberhard F. Mammen Award Announcements: Part II-Young Investigator Awards. Semin Thromb Hemost 2024;50(8):1049–1057 31. Favaloro EJ. 2025 Eberhard F. Mammen Award Announcements: Part I-Most Popular Articles. Semin Thromb Hemost. 2025;51(4):366–380 32. Favaloro EJ. 2024 Eberhard F. Mammen Award Announcements: Part II-Young Investigator Awards. Semin Thromb Hemost 2025;51(5):481–490 33. Favaloro EJ. 2026 Eberhard F. Mammen Award Announcements: Part I-Most Popular Articles. Semin Thromb Hemost 2026;in press (doi: 10.1055/a-2811-4911). ➢ Most popular article awards: awarded to the authors of the most popular articles published in STH in the preceding 2 years, as captured in the preceding year. The awards are determined by the Editor in Chief on the basis of user statistics from Thieme e-Journals. Prefaces, Errata, Letters to the Editor, Editorials, short Commentaries, and previous award-winning articles are excluded from further consideration of these awards, which currently comprise two categories—one for “Free Access” articles, and another for a “General Category.” There are two major cash prizes of US$1,000 for each category. In addition, winners of the “General Category” awards are granted “Free Access” status for these articles thereafter. ➢ Young investigator awards: best presentation or meeting abstract by a young investigator, as presented or delivered to an international or large regional meeting on a topic related to the fields of thrombosis and hemostasis, and whose subject matter is determined to be in the spirit of Dr. Mammen. Up to six cash prizes of US$1,000 in any year. There are some additional considerations and conditions for the award, and awardees are expected to prepare a review or other paper related to the topic of their presentation (or as otherwise agreed) for publication in STH. Previous award winners are excluded from a second award to enable more individuals to be recognized. After nominations are received, the awardees are selected by a vote of the Senior Editors of STH. Any potential conflicts of interest are managed by first identifying them and then excluding those with potential conflicts from voting. Finally, given the increased potential of virtual meetings, virtual presentations can also be considered for the award. Further details of the awards and the award winners are posted online ( https://www.thieme-connect.com/products/ejournals/journal/10.1055/s-00000077 ), and previous award winner announcements are also available in print (see [ Table 1 ] for a listing of relevant editorials published in this journal as related to the initiation of the Eberhard F. Mammen awards, as well as previous award announcements; these publications are also available for free download from the journal website: https://www.thieme-connect.com/products/ejournals/journal/10.1055/s-00000077 ). The winners of the latest Eberhard F. Mammen award for the most popular articles from STH for the period of 2024 to 2025 inclusive (as accessed in 2025) were announced in an earlier issue of the journal,[ 1 ] as were the previous Eberhard F. Mammen awards for the most popular articles from STH for the periods of 2023 to 2024 inclusive (as accessed in 2024) and 2022 to 2023 inclusive (as accessed in 2023).[ 2 ] [ 3 ] These editorials are free to download. The previous Young Investigator awards editorial is also available and free to download.[ 4 ] It is therefore with great pleasure that we would like to announce the winners of the latest round of Young Investigator awards. As mentioned above, the Young Investigator Awards represent winners of the best presentation or meeting abstract by a young investigator, as presented or delivered to an international or large regional meeting (virtual meetings permissible) on a topic related to the fields of thrombosis and hemostasis, and whose subject matter is determined to be in the spirit of Dr. Mammen. There are additional considerations, given that the nominees' presentations are not necessarily seen by all of the possible award nominators, being drawn from the broader editorial team of the journal, as well as potentially from outside the editorial team, nor necessarily seen by all the voting team (comprising the senior editors of the journal). The latest winners are identified below, with a running list of previous awardees and their resulting publications in the journal, given in [ Table 2 ]. The latest awardees were derived from presentations at recent meetings of the International Society on Thrombosis and Haemostasis (ISTH), the American Society of Hematology (ASH), and the Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ). Table 2 Publications arising from previous Eberhard F. Mammen Young Investigator Award winners[ a ] Awardee Year awarded Publication arising Willem M. Lijfering 2009 Lijfering WM, Flinterman LE, Vandenbroucke JP, Rosendaal FR, Cannegieter SC. Relationship between venous and arterial thrombosis: a review of the literature from a causal perspective. Semin Thromb Hemost 2011 Nov;37(8):885–896. Salley Pels 2009 Pels SG. Current therapies in primary immune thrombocytopenia. Semin Thromb Hemost 2011 Sep;37(6):621–630. Adam Cuker 2010 Cuker A. Current and emerging therapeutics for heparin-induced thrombocytopenia. Semin Thromb Hemost 2012 Feb;38(1):31–37. Giridhara R. Jayandharan 2010 Jayandharan GR, Srivastava A, Srivastava A. Role of molecular genetics in hemophilia: from diagnosis to therapy. Semin Thromb Hemost 2012 Feb;38(1):64–78. Timea Szanto 2010 Szántó T, Joutsi-Korhonen L, Deckmyn H, Lassila R. New insights into von Willebrand disease and platelet function. Semin Thromb Hemost 2012 Feb;38(1):55–63. Birgitta Salmela 2010 Salmela B, Joutsi-Korhonen L, Armstrong E, Lassila R. Active online assessment of patients using new oral anticoagulants: bleeding risk, compliance, and coagulation analysis. Semin Thromb Hemost 2012 Feb;38(1):23–30. Pia R.-M. Siljander 2010 Aatonen M, Grönholm M, Siljander PR. Platelet-derived microvesicles: multitalented participants in intercellular communication. Semin Thromb Hemost 2012 Feb;38(1):102–113. Romaric Lacroix 2011 Lacroix R, Dignat-George F. Microparticles: new protagonists in pericellular and intravascular proteolysis. Semin Thromb Hemost 2013 Feb;39(1):33–39. Brad McEwen 2011 McEwen BJ, Morel-Kopp MC, Chen W, Tofler GH, Ward CM. Effects of omega-3 polyunsaturated fatty acids on platelet function in healthy subjects and subjects with cardiovascular disease. Semin Thromb Hemost 2013 Feb;39(1):25–32. Neil A. Goldenberg 2011 Bernard TJ, Armstrong-Wells J, Goldenberg NA. The institution-based prospective inception cohort study: design, implementation, and quality assurance in pediatric thrombosis and stroke research. Semin Thromb Hemost 2013 Feb;39(1):10–14. Vivien Chen 2011 Chen VM. Tissue factor de-encryption, thrombus formation, and thiol-disulfide exchange. Semin Thromb Hemost 2013 Feb;39(1):40–47. Joseph E. Italiano, Jr. 2011 Italiano JE Jr. Unraveling mechanisms that control platelet production. Semin Thromb Hemost 2013 Feb;39(1):15–24. Vivian X. Du 2012/2013 Du VX, Huskens D, Maas C, Al Dieri R, de Groot PG, de Laat B. New insights into the role of erythrocytes in thrombus formation. Semin Thromb Hemost 2014 Feb;40(1):72–80. Andrew Yee 2012/2013 Yee A, Kretz CA. Von Willebrand factor: form for function. Semin Thromb Hemost 2014 Feb;40(1):17–27. Sarah O'Brien 2012/2013 O'Brien SH. Contraception-related venous thromboembolism in adolescents. Semin Thromb Hemost 2014 Feb;40(1):66–71. Veronica Flood 2012/2013 Flood VH. Perils, problems, and progress in laboratory diagnosis of von Willebrand disease. Semin Thromb Hemost 2014 Feb;40(1):41–48. Julie Tange 2012/2013 Tange JI, Grill D, Koch CD, et al. Local verification and assignment of mean normal prothrombin time and international sensitivity index values across various instruments: recent experience and outcome from North America. Semin Thromb Hemost 2014 Feb;40(1):115–120. Kent Chapman 2012/2013 Chapman K, Yuen S. Therapy for thrombotic thrombocytopenia purpura: past, present, and future. Semin Thromb Hemost 2014 Feb;40(1):34–40. Andreas Tiede 2014 Tiede A, Werwitzke S, Scharf RE. Laboratory diagnosis of acquired hemophilia a: limitations, consequences, and challenges. Semin Thromb Hemost 2014 Oct;40(7):803–811 Wendy Lim 2014 Lim W. Thrombotic risk in the antiphospholipid syndrome. Semin Thromb Hemost 2014 Oct;40(7):741–746. Susana N. Fernandes 2014 Fernandes S, Carvalho M, Lopes M, Araújo F. Impact of an individualized prophylaxis approach on young adults with severe hemophilia. Semin Thromb Hemost 2014 Oct;40(7):785–789. Maria E. Mancuso 2014 Mancuso ME, Fasulo MR. Thrombin generation assay as a laboratory monitoring tool during by-passing therapy in patients with hemophilia and inhibitors. Semin Thromb Hemost 2016 Feb;42(1):30–35. Coen Maas 2014 Tersteeg C, Fijnheer R, Deforche L, et al. Keeping von Willebrand factor under control: alternatives for ADAMTS13. Semin Thromb Hemost 2016 Feb;42(1):9–17. Riten Kumar 2014 Kumar R, Dunn A, Carcao M. Changing paradigm of hemophilia management: extended half-life factor concentrates and gene therapy. Semin Thromb Hemost 2016 Feb;42(1):18–29. Juraj Sokol 2015 Sokol J, Skerenova M, Jedinakova Z, et al. Progress in the understanding of sticky platelet syndrome. Semin Thromb Hemost 2017;43(1):8–13 Ljubica Jovanović 2015 Jovanovic L, Antonijevic N, Novakovic T, et al. Practical aspects of monitoring of antiplatelet therapy. Semin Thromb Hemost 2017;43(1):14–23 Lucia Stanciakova 2015 Stanciakova L, Dobrotova M, Jedinakova Z, et al. Monitoring of hemostasis and management of anticoagulant thromboprophylaxis in pregnant women with increased risk of fetal loss. Semin Thromb Hemost 2016 Sep;42(6):612–621. Tina Biss 2015 Biss TT. Venous thromboembolism in children: is it preventable? Semin Thromb Hemost 2016 Sep;42(6):603–611. Tobias Fuchs 2015 Jiménez-Alcázar M, Kim N, Fuchs TA. Circulating extracellular DNA: cause or consequence of thrombosis? Semin Thromb Hemost 2017 Sep;43(6):553–561 Jonathan M. Coutinho 2015 Silvis SM, Middeldorp S, Zuurbier SM, Cannegieter SC, Coutinho JM. Risk factors for cerebral venous thrombosis. Semin Thromb Hemost 2016 Sep;42(6):622–631. Soundarya Selvam 2016 Selvam S, James P. Angiodysplasia in von Willebrand disease: understanding the clinical and basic science. Semin Thromb Hemost 2017 Sep;43(6):572–580. Vincent Muczynski 2016 Muczynski V, Christophe OD, Denis CV, Lenting PJ. Emerging therapeutic strategies in the treatment of hemophilia A. Semin Thromb Hemost 2017 Sep;43(6):581–590. Karen Schreiber 2016 Schreiber K, Breen K, Cohen H, et al. Hydroxychloroquine to improve pregnancy outcome in women with antiphospholipid antibodies (HYPATIA) protocol: a multinational randomized controlled trial of hydroxychloroquine versus placebo in addition to standard treatment in pregnant women with antiphospholipid syndrome or antibodies. Semin Thromb Hemost 2017 Sep;43(6):562–571. Jasmine W. T. Tay 2016 Tay J, Tiao J, Hughes Q, Jorritsma J, Gilmore G, Baker R. Circulating microRNA as thrombosis sentinels: caveats and considerations. Semin Thromb Hemost 2018 Apr;44(3):206–215. Adi J. Klil-Drori 2016 Klil-Drori AJ, Tagalakis V. Direct oral anticoagulants in end-stage renal disease. Semin Thromb Hemost 2018 Jun;44(4):353–363. Ivar van Asten 2017 van Asten I, Schutgens REG, Urbanus RT. Toward flow cytometry based platelet function diagnostics. Semin Thromb Hemost 2018 Apr;44(3):197–205. Elodie Laridan 2017 Laridan E, Martinod K, De Meyer SF. Neutrophil extracellular traps in arterial and venous thrombosis. Semin Thromb Hemost 2019 Feb;45(1):86–93. Leonardo Pasalic 2017 Blennerhassett R, Curnow J, Pasalic L. Immune-mediated thrombotic thrombocytopenic purpura: a narrative review of diagnosis and treatment in adults. Semin Thromb Hemost 2020 Apr;46(3):289–301 Yvonne Brennan 2017 Brennan Y, Favaloro EJ, Curnow J. To maintain or cease non-vitamin K antagonist oral anticoagulants prior to minimal bleeding risk procedures: a review of evidence and recommendations. Semin Thromb Hemost 2019 Mar;45(2):171–179. Mark Schreuder 2018 Schreuder M, Reitsma PH, Bos MHA. Reversal agents for the direct factor xa inhibitors: biochemical mechanisms of current and newly emerging therapies. Semin Thromb Hemost 2020 Nov;46(8):986–998 James McFadyen 2018 Stevens H, McFadyen JD. Platelets as central actors in thrombosis-reprising an old role and defining a new character. Semin Thromb Hemost 2019 Nov;45(8):802–809. David Rabbolini 2018 Mason GA, Rabbolini DJ. The current role of platelet function testing in clinical practice. Semin Thromb Hemost 2021 Oct;47(7):843–854. Janka Zolkova 2018 Zolkova J, Sokol J, Simurda T, et al. Genetic